U.S. lawmakers call on the government to scrutinize drugmakers' clinical trials in China; China removes restrictions for foreign investments in the manufacturing and services industries; and Cross-Boundary Wealth Connect gains 10 new additional securities firms for increased offshore investment opportunities.
Revised Chinese Company Law requires mandatory worker representation in boardrooms; Shanghai's biomedical measures catch the most attention; and Merchants of Pinduoduo's international arm, Temu, struggle to sue the company due to its complex structure.
WeRide IPO shows another green light for overseas listing of Chinese companies; China imposes new regulations for local authorities to better implement its state secrets law overhaul; and two Chinese state departments release new rules for QFII to stimulate foreign securities investment.
U.S. lawmakers are worried about Microsoft's deal with a UAE-based AI company that has China ties; Nippon Steel ends joint venture with Baoshan; and China tightens regulation on hedge funds and programmed trading.
The Supreme People's Court releases "typical cases" as a guide for the application of extraterritorial laws in Chinese courts; Chinese tech companies anticipate increased costs under the EU AI Act; and Foreign investors face increased domestic competition in China.
Geoffrey Chan and Angela Liu of Skadden, Arps, Slate, Meagher & Flom in Hong Kong examine key structuring considerations for international companies planning to establish a corporate venture capital arm in China or elsewhere in Asia